<qa>  What is the population of the study population?This study is a single arm Phase II, multicenter trial. It is designed to determine whether the anticipated endpoints for a T cell depleted transplant arm of a planned prospective randomized trial comparing T cell depleted and unmodified hematopoietic allografts are likely to be achieved in a multicenter study conducted by the Blood and Marrow Transplant Clinical Trials Network BMT CTN or Network. The study population is patients with acute myeloid leukemia AML in first or second morphologic complete remission. The enrollment is 45 patients. 